News and Trends 31 Mar 2023
Destiny Pharma gel reduces nasal staph in surgery patients
Destiny Pharma has revealed data showing its drug reduced Staphylococcus aureus in the nasal passage of pre-op cardiac surgery patients. Destiny Pharma is a clinical stage biotechnology company focused on…